These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
174 related articles for article (PubMed ID: 24587462)
1. Deletion of ubiquitin fold modifier protein Ufm1 processing peptidase Ufsp in L. donovani abolishes Ufm1 processing and alters pathogenesis. Gannavaram S; Davey S; Lakhal-Naouar I; Duncan R; Nakhasi HL PLoS Negl Trop Dis; 2014 Feb; 8(2):e2707. PubMed ID: 24587462 [TBL] [Abstract][Full Text] [Related]
2. Deletion of mitochondrial associated ubiquitin fold modifier protein Ufm1 in Leishmania donovani results in loss of β-oxidation of fatty acids and blocks cell division in the amastigote stage. Gannavaram S; Connelly PS; Daniels MP; Duncan R; Salotra P; Nakhasi HL Mol Microbiol; 2012 Oct; 86(1):187-98. PubMed ID: 22897198 [TBL] [Abstract][Full Text] [Related]
3. Leishmania donovani-specific Ub-related modifier-1: an early endosome-associated ubiquitin-like conjugation in Leishmania donovani. Sharma V; Sharma P; Selvapandiyan A; Salotra P Mol Microbiol; 2016 Feb; 99(3):597-610. PubMed ID: 26481108 [TBL] [Abstract][Full Text] [Related]
4. Antiparasitic dibenzalacetone inhibits the GTPase activity of Rab6 protein of Leishmania donovani (LdRab6), a potential target for its antileishmanial effect. Chauhan IS; Marwa S; Rao GS; Singh N Parasitol Res; 2020 Sep; 119(9):2991-3003. PubMed ID: 32748038 [TBL] [Abstract][Full Text] [Related]
5. Reduced pathogenicity of fructose-1,6-bisphosphatase deficient Leishmania donovani and its use as an attenuated strain to induce protective immunogenicity. Saini S; Ghosh AK; Das S; Singh R; Abhishek K; Verma S; Kumar A; Mandal A; Purkait B; Sinha KK; Das P Vaccine; 2018 Feb; 36(9):1190-1202. PubMed ID: 29395522 [TBL] [Abstract][Full Text] [Related]
6. Deletion of an ATP-binding cassette protein subfamily C transporter in Leishmania donovani results in increased virulence. Zhang WW; Matlashewski G Mol Biochem Parasitol; 2012 Oct; 185(2):165-9. PubMed ID: 22841683 [TBL] [Abstract][Full Text] [Related]
8. Loss of virulence in Leishmania donovani deficient in an amastigote-specific protein, A2. Zhang WW; Matlashewski G Proc Natl Acad Sci U S A; 1997 Aug; 94(16):8807-11. PubMed ID: 9238059 [TBL] [Abstract][Full Text] [Related]
9. Leishmania donovani Parasites Are Inhibited by the Benzoxaborole AN2690 Targeting Leucyl-tRNA Synthetase. Manhas R; Tandon S; Sen SS; Tiwari N; Munde M; Madhubala R Antimicrob Agents Chemother; 2018 Sep; 62(9):. PubMed ID: 29941647 [TBL] [Abstract][Full Text] [Related]
10. Studies on the CPA cysteine peptidase in the Leishmania infantum genome strain JPCM5. Denise H; Poot J; Jiménez M; Ambit A; Herrmann DC; Vermeulen AN; Coombs GH; Mottram JC BMC Mol Biol; 2006 Nov; 7():42. PubMed ID: 17101050 [TBL] [Abstract][Full Text] [Related]
11. Two novel ubiquitin-fold modifier 1 (Ufm1)-specific proteases, UfSP1 and UfSP2. Kang SH; Kim GR; Seong M; Baek SH; Seol JH; Bang OS; Ovaa H; Tatsumi K; Komatsu M; Tanaka K; Chung CH J Biol Chem; 2007 Feb; 282(8):5256-62. PubMed ID: 17182609 [TBL] [Abstract][Full Text] [Related]
13. Leishmania donovani lacking the Golgi GDP-Man transporter LPG2 exhibit attenuated virulence in mammalian hosts. Gaur U; Showalter M; Hickerson S; Dalvi R; Turco SJ; Wilson ME; Beverley SM Exp Parasitol; 2009 Jul; 122(3):182-91. PubMed ID: 19328787 [TBL] [Abstract][Full Text] [Related]
14. Structural basis for Ufm1 recognition by UfSP. Kim KH; Ha BH; Kim EE FEBS Lett; 2018 Jan; 592(2):263-273. PubMed ID: 29251776 [TBL] [Abstract][Full Text] [Related]
15. Cathepsin B gene disruption induced Leishmania donovani proteome remodeling implies cathepsin B role in secretome regulation. Gerbaba TK; Gedamu L PLoS One; 2013; 8(11):e79951. PubMed ID: 24244582 [TBL] [Abstract][Full Text] [Related]
16. Specific cpb copies within the Leishmania donovani complex: evolutionary interpretations and potential clinical implications in humans. Hide M; Bras-Gonçalves R; Bañuls AL Parasitology; 2007 Mar; 134(Pt 3):379-89. PubMed ID: 17129395 [TBL] [Abstract][Full Text] [Related]
17. Genetic manipulation of Leishmania donovani threonyl tRNA synthetase facilitates its exploration as a potential therapeutic target. Chadha S; Vijayan R; Gupta S; Munde M; Gourinath S; Madhubala R PLoS Negl Trop Dis; 2018 Jun; 12(6):e0006575. PubMed ID: 29897900 [TBL] [Abstract][Full Text] [Related]
18. The Leishmania donovani histidine acid ecto-phosphatase LdMAcP: insight into its structure and function. Papadaki A; Politou AS; Smirlis D; Kotini MP; Kourou K; Papamarcaki T; Boleti H Biochem J; 2015 May; 467(3):473-86. PubMed ID: 25695743 [TBL] [Abstract][Full Text] [Related]
19. Leishmania donovani ornithine decarboxylase is indispensable for parasite survival in the mammalian host. Boitz JM; Yates PA; Kline C; Gaur U; Wilson ME; Ullman B; Roberts SC Infect Immun; 2009 Feb; 77(2):756-63. PubMed ID: 19064633 [TBL] [Abstract][Full Text] [Related]
20. Structural basis for Ufm1 processing by UfSP1. Ha BH; Ahn HC; Kang SH; Tanaka K; Chung CH; Kim EE J Biol Chem; 2008 May; 283(21):14893-900. PubMed ID: 18321862 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]